1. Catalog
  2. Journal Club: The Efficacy and Safety of Mirvetuxi ...
Image For Activity Cover
Journal Club: The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial
Description

Listen to a new Journal Club with lead author Dr. Angeles Alvarez Secord and moderator Dr. Robert Coleman as they discuss details on the recently published article The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial. Click here to read the article  

Recording will be available Tuesday, December 17th. 

Presented by:

A person in a black suitDescription automatically generated

Angeles Alvarez Secord, MD, MHSc
Professor of Obstetrics and Gynecology
Duke University School of Medicine
USA

Moderated by:

A person in a suit and tieDescription automatically generated

Robert Coleman, MD, FACOG, FACS
Chief Medical Officer
Vaniam Group
USA

 

Supported in part by
Summary
Availability: On-Demand
Cost: FREE
Create Account
Recommended
Contact education@igcs.org for assistance.
Powered By